Investigative Ophthalmology & Visual Science Cover Image for Volume 59, Issue 9
July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Optical Coherence Tomography Angiography findings in patients with Fabry's disease
Author Affiliations & Notes
  • Joel Baur
    Ophthalmology, University Hospital Zürich, Zürich, Schweiz, Switzerland
  • Mayss Al-Sheikh
    Ophthalmology, University Hospital Zürich, Zürich, Schweiz, Switzerland
  • Daniel Barthelmes
    Ophthalmology, University Hospital Zürich, Zürich, Schweiz, Switzerland
  • Albina Nowak
    University Hospital Zürich, Zürich, Schweiz, Switzerland
  • Christian Böni
    Ophthalmology, University Hospital Zürich, Zürich, Schweiz, Switzerland
  • Sandrine Anne Zweifel
    Ophthalmology, University Hospital Zürich, Zürich, Schweiz, Switzerland
  • Footnotes
    Commercial Relationships   Joel Baur, None; Mayss Al-Sheikh, None; Daniel Barthelmes, None; Albina Nowak, None; Christian Böni, None; Sandrine Zweifel, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4249. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joel Baur, Mayss Al-Sheikh, Daniel Barthelmes, Albina Nowak, Christian Böni, Sandrine Anne Zweifel; Optical Coherence Tomography Angiography findings in patients with Fabry's disease. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4249.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Fabry disease (FD) is an X-linked recessive hereditary lysosomal storage disorder which results in the accumulation of glycosphingolipids in various organs including the eye. Ocular manifestation of FD include cornea verticillata and conjunctival and retinal vascular abnormalities. The purpose of this study was to analyze the retinal vasculature using swept-source optical coherence tomography angiography (SS OCTA) in patients with FD.

Methods : Images (a 3x3 and 6x6 mm cube centered on the fovea) were acquired in 16 eyes of 8 healthy individuals and 28 eyes of 14 patients with FD using a SS OCTA device (central wavelength 1060 nm; A-scan rate of 100,000 scans per second). The data analysed were taken from one eye only of each subject. En face images of the retinal vasculature were generated from the superficial and deep capillary plexus (SCP/DCP). Quantitative analysis of the vessel density (VD) and vessel length density (VLD) was performed manually. Vessel density was assessed as the ratio of the retinal area occupied by vessels. Vessel length density was measured as the total length of the skeletonized vessels using 1-pixel centreline extraction of the blood vessels.

Results : Among the patients with FD the mean age was 47 (±14 SD) years with 43% male and in the healthy individuals 29 years (±5 SD) with 25% male. The mean VD of the SCP in FD-group was 0.47 (3x3mm) / 0.46 (6x6mm), the VLD of SCP was 25.30 (3x3mm) / 19.89mm-1 (6x6mm), the VD of DCP was 0.46 (3x3mm) / 0.47 (6x6mm) and the VLD of DCP was 25.56 (3x3mm) / 21.07mm-1 (6x6mm). In the control group the mean VD of SRL was 0.49 (3x3mm) / 0.48 (6x6mm), the VLD of SCP was 25.87 (3x3mm) / 20.85mm-1 (6x6mm), the VD of DCP was 0.50 (3x3mm) / 0.49 (6x6mm) and the VLD of DCP was 27.01 (3x3mm) / 21.94mm-1 (6x6mm). There was a statistically significant reduction in both VD and VLD of DCP in FD group (p<0.05) compared to controls. Further there was a statistically significant reduction of VLD of SCP in 6x6mm cubes.

Conclusions : Swept-source OCTA of the microcirculation in eyes of patients with FD can be used to quantitatively demonstrate alterations in the superficial and deep capillary plexus compared to healthy eyes. The reduction of the capillary network in the deep capillary plexus could be clinically significant and future longitudinal studies may use these metrics to evaluate changes over time and its correlation to disease severity.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×